AbbVie
ABBV
#33
Rank
ยฃ273.17 B
Marketcap
ยฃ154.45
Share price
-0.29%
Change (1 day)
22.49%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of December 2025 : ยฃ3.89 Billion

According to AbbVie's latest financial reports the company has ยฃ3.89 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ3.90 B-11.82%
2024-12-31ยฃ4.42 B-56%
2023-12-31ยฃ10.05 B31.87%
2022-12-31ยฃ7.62 B4.75%
2021-12-31ยฃ7.28 B17.07%
2020-12-31ยฃ6.22 B-79.57%
2019-12-31ยฃ30.44 B379.43%
2018-12-31ยฃ6.35 B-12.32%
2017-12-31ยฃ7.24 B39.14%
2016-12-31ยฃ5.20 B-8.24%
2015-12-31ยฃ5.67 B5.47%
2014-12-31ยฃ5.37 B-10.34%
2013-12-31ยฃ5.99 B21.56%
2012-12-31ยฃ4.93 B1074.59%
2011-12-31ยฃ0.42 B5919.07%
2010-12-31ยฃ6.97 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
ยฃ10.07 B 158.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ5.38 B 38.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.76 B 73.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ2.82 B-27.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.12 B 82.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.91 B 103.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ4.23 B 8.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ3.15 B-19.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ1.09 B-71.84%๐Ÿ‡บ๐Ÿ‡ธ USA